Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Weighted Average and Diluted): 2021-2025

Historic EPS (Weighted Average and Diluted) for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -$1.16.

  • Biodesix's EPS (Weighted Average and Diluted) rose 17.14% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 331.58%. This contributed to the annual value of -$0.33 for FY2024, which is 48.44% up from last year.
  • Biodesix's EPS (Weighted Average and Diluted) amounted to -$1.16 in Q3 2025, which was down 1,350.00% from -$0.08 recorded in Q2 2025.
  • Biodesix's EPS (Weighted Average and Diluted)'s 5-year high stood at $5.28 during Q4 2024, with a 5-year trough of -$4.52 in Q2 2021.
  • Its 3-year average for EPS (Weighted Average and Diluted) is $0.15, with a median of -$0.14 in 2024.
  • Data for Biodesix's EPS (Weighted Average and Diluted) shows a peak YoY increase of 5,966.67% (in 2024) and a maximum YoY decrease of 900.00% (in 2024) over the last 5 years.
  • Biodesix's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.49 in 2021, then soared by 32.65% to -$0.33 in 2022, then surged by 72.73% to -$0.09 in 2023, then surged by 5,966.67% to $5.28 in 2024, then increased by 17.14% to -$1.16 in 2025.
  • Its last three reported values are -$1.16 in Q3 2025, -$0.08 for Q2 2025, and -$0.08 during Q1 2025.